CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVO

Insulin Icodec

Phase 3
Novo Nordisk A/S (NVO)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jan '27
NVOPhase 3

Insulin icodec Phase 3 Est. Readout

Insulin Icodec
Jan 2027~
CT.gov
00%
Drug Information

Target Indication

Diabetes Mellitus, Type 2

Clinical Trial

NCT05823948

Last updated: 12/8/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMA5/17/2024

Awiqli

Treatment of diabetes mellitus in adults

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.